doi: 10.3389/fpsyt.2025.1589688 Received 07 March 2025 Accepted 17 June 2025 Published 22 July 2025 Volume 16 - 2025 Edited by Mauro Ceccanti, Sapienza University of Rome, Italy Reviewed by Marcos Edgar Herkenhoff, Santa Catarina State University, Brazil Amarveer Malhi, Caribbean Medical University School of Medicine, Curaao Updates Copyright 2025 Waller, Ho, Batzler, Geske, Karpyak, Biernacka and Winham
doi:10.1136/bmjopen-2016-011045
If you choose a tincture or encapsulated formulation, then take as directed by the manufacturer
159 Shifting domestic financing towards drugs for priority interventions Section 5 of this report proposes mCEA as a means of prioritising interventions and shifting budget allocations towards the delivery systems for these interventions
Intravenous users are at increased risk for viral hepatitis if they use contaminated needles
9 , eadg9175 (2023)